Combination of budesonide/formoterol in a single inhaler
- In selected adult patients at Step 3 who are poorly controlled or in selected patients at step 2 (>400mcg BDP/day who are poorly controlled) the use of budesonide/formoterol in a single inhaler as rescue medication instead of a short acting b2agonist, in addition to its regular use as a preventative (controller) treatment, has been shown to be effective.
- When this management option is introduced the total regular dose of daily inhaled steroids should not be decreased
- The regular daily dose of ICS may be Budesonide 200mcg bd or 400mcg bd
- Patients taking rescue budesonide/formoterol once/day or more should have their treatment reviewed
- Before instituting this management careful patient education is required.
- This management technique has not been investigated with other combination inhalers.
Back to Management of asthma in adults